The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Michael J. Berendt net worth and biography

Michael Berendt Biography and Net Worth

Director of Waters

Dr. Michael Joseph Berendt, Ph.D., is Independent Director of Waters Corporation. Since December 2016, Dr. Berendt has been a life sciences industry consultant. From November 2013 to November 2016, Dr. Berendt was the Chief Executive Officer and Chief Scientist of Telesta Therapeutics. From July 2011 to November 2013, Dr. Berendt was a life sciences industry consultant. From March 2006 to July 2011, Dr. Berendt served as the President and Chief Executive Officer of Aegera Therapeutics Inc. From August 2004 to December 2005, Dr. Berendt served as Managing Director of Research Corporation Technologies, Inc. From November 2000 to August 2004, Dr. Berendt served as Managing Director of AEA Investors LP. Dr. Berendt also worked for 18 years, from 1982 to 2000, in the pharmaceutical industry where he served in a number of senior management positions including Senior Vice President of Research for the Pharmaceutical Division of Bayer Corporation, and a Group Director of Drug Discovery at Pfizer, Inc. Dr. Berendt’s experience in the pharmaceutical industry both from a management and a scientific perspective provides unique technical insight to the Waters Board. In addition, Dr. Berendt’s years of experience as a Chief Executive Officer and as a senior financial executive, affords the Waters Board the benefit of his financial and business strategy skills.

What is Michael J. Berendt's net worth?: The estimated net worth of Michael J. Berendt is at least $6.14 million as of August 12th, 2021. Mr. Berendt owns 16,449 shares of Waters stock worth more than $6,143,208 as of November 23rd. This net worth approximation does not reflect any other investments that Mr. Berendt may own. Learn More about Michael J. Berendt's net worth.
How do I contact Michael J. Berendt?: The corporate mailing address for Mr. Berendt and other Waters executives is 34 MAPLE STREET, MILFORD MA, 01757. Waters can also be reached via phone at (508) 478-2000 and via email at [email protected]. Learn More on Michael J. Berendt's contact information.
Has Michael J. Berendt been buying or selling shares of Waters?: Michael J. Berendt has not been actively trading shares of Waters during the last ninety days. Most recently, Michael J. Berendt sold 4,000 shares of the business's stock in a transaction on Thursday, August 12th. The shares were sold at an average price of $398.43, for a transaction totalling $1,593,720.00. Following the completion of the sale, the director now directly owns 16,449 shares of the company's stock, valued at $6,553,775.07. Learn More on Michael J. Berendt's trading history.
Who are Waters' active insiders?: Waters' insider roster includes Linda Baddour (Director), Michael Berendt (Director), Sherry Buck (Former CFO), Robert Carson (SVP), Edward Conard (Director), Richard Fearon (Director), Michael Harrington (SVP), Ian King (SVP), Christopher Kuebler (Director), Christopher O'Connell (CEO), JoAnn Reed (Director), Thomas Salice (Director), and Mark Vergnano (Director). Learn More on Waters' active insiders.
Are insiders buying or selling shares of Waters?: During the last twelve months, Waters insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $332,900.00. During the last twelve months, insiders at the medical instruments supplier sold shares 2 times. They sold a total of 4,500 shares worth more than $1,624,330.00. The most recent insider tranaction occured on May, 28th when Director Richard H Fearon bought 1,000 shares worth more than $332,900.00. Insiders at Waters own 0.8% of the company. Learn More about insider trades at Waters.
Information on this page was last updated on 5/28/2024.

Michael J. Berendt Insider Trading History at Waters

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/12/2021	Sell	4,000	$398.43	$1,593,720.00	16,449
5/24/2021	Sell	1,161	$318.24	$369,476.64	21,255
11/9/2020	Sell	4,000	$230.10	$920,400.00	25,977
2/25/2019	Sell	3,000	$239.64	$718,920.00	21,510
1/2/2019	Sell	3,500	$184.74	$646,590.00	27,411
5/10/2017	Sell	1,000	$174.01	$174,010.00	23,349
12/8/2015	Sell	4,000	$130.54	$522,160.00	18,700
6/18/2015	Sell	1,500	$136.44	$204,660.00
5/15/2013	Sell	4,000	$98.79	$395,160.00

Michael J. Berendt Buying and Selling Activity at Waters

Waters Company Overview

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Today's Range

Now: $373.47

$365.86

$374.21

50 Day Range

MA: $354.04

$322.57

$387.34

2 Week Range

Now: $373.47

$273.60

$393.38

Volume

366,273 shs

Average Volume

575,703 shs

Market Capitalization

$22.18 billion

P/E Ratio

35.64

Dividend Yield

N/A

Beta

0.97

Financial Prophecy

From Porter & Company | Ad